TY - JOUR TI - Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 AU - Gregory A. Roth AU - Catherine O. Johnson AU - Amanuel Alemu Abajobir AU - Foad Abd-Allah AU - Semaw Ferede Abera AU - Gebre Yitayih Abyu AU - Muktar Beshir Ahmed AU - Baran Aksut AU - Shazia Alam AU - Khurshid Alam AU - François Alla AU - Nelson Alvis‐Guzmán AU - Stephen M. Amrock AU - Hossein Ansari AU - Johan Ärnlöv AU - Hamid Asayesh AU - Tesfay Mehari Atey AU - Leticia Ávila‐Burgos AU - Ashish Awasthi AU - Amitava Banerjee AU - Aleksandra Barać AU - Till Bärnighausen AU - Lars Barregård AU - Neeraj Bedi AU - Ezra B. Ketema AU - Derrick Bennett AU - Gebremedhin Berhe AU - Zulfiqar A Bhutta AU - Shimelash Bitew Workie AU - Jonathan R. Carapetis AU - Juan Jesús Carrero AU - Déborah Carvalho Malta AU - Carlos A Castañeda-Orjuela AU - Jacqueline Castillo-Rivas AU - Ferrán Catalá-López AU - Jee-Young Choi AU - Hanne Christensen AU - Massimo Círillo AU - Leslie T. Cooper AU - Michael H Criqui AU - David K Cundiff AU - Albertino Damasceno AU - Lalit Dandona AU - Rakhi Dandona AU - Kairat Davletov AU - Samath Dhamminda Dharmaratne AU - Prabhakaran Dorairaj AU - Manisha Dubey AU - Rebecca Ehrenkranz AU - Maysaa El Sayed Zaki AU - Emerito Jose A Faraon AU - Alireza Esteghamati AU - Talha Farid AU - Maryam S. Farvid AU - Valery L. Feigin AU - Eric L. Ding AU - Gerry Fowkes AU - Tsegaye Gebrehiwot AU - Richard F Gillum AU - Audra L Gold AU - Philimon Gona AU - Rajeev Gupta AU - Tesfa Dejenie Habtewold AU - Nima Hafezi‐Nejad AU - Tesfayé Hailu AU - Gessessew Bugssa Hailu AU - Graeme J. Hankey AU - Hamid Yimam Hassen AU - Kalkidan Hassen Abate AU - Rasmus Havmoeller AU - Simon I Hay AU - Masako Horino AU - Peter J. Hotez AU - Kathryn H. Jacobsen AU - Spencer L James AU - Mehdi Javanbakht AU - Panniyammakal Jeemon AU - Denny John AU - Jost B. Jonas AU - Yogeshwar Kalkonde AU - Chanté Karimkhani AU - Amir Kasaeian AU - Yousef Khader AU - Abdur Rahman Khan AU - Young‐Ho Khang AU - Sahil Khera AU - Abdullah T Khoja AU - Jagdish Khubchandani AU - Daniel Kim AU - Dhaval Kolte AU - Soewarta Kosen AU - Kristopher J Krohn AU - G Anil Kumar AU - Gene F. Kwan AU - Dharmesh Kumar Lal AU - Anders Larsson AU - Shai Linn AU - Alan D Lopez AU - Paulo A. Lotufo AU - Hassan Magdy Abd El Razek PY - 2017 JO - Journal of the American College of Cardiology DO - 10.1016/j.jacc.2017.04.052 UR - https://doi.org/10.1016/j.jacc.2017.04.052 AB - BACKGROUND: The burden of cardiovascular diseases (CVDs) remains unclear in many regions of the world. OBJECTIVES: The GBD (Global Burden of Disease) 2015 study integrated data on disease incidence, prevalence, and mortality to produce consistent, up-to-date estimates for cardiovascular burden. METHODS: CVD mortality was estimated from vital registration and verbal autopsy data. CVD prevalence was estimated using modeling software and data from health surveys, prospective cohorts, health system administrative data, and registries. Years lived with disability (YLD) were estimated by multiplying prevalence by disability weights. Years of life lost (YLL) were estimated by multiplying age-specific CVD deaths by a reference life expectancy. A sociodemographic index (SDI) was created for each location based on income per capita, educational attainment, and fertility. RESULTS: In 2015, there were an estimated 422.7 million cases of CVD (95% uncertainty interval: 415.53 to 427.87 million cases) and 17.92 million CVD deaths (95% uncertainty interval: 17.59 to 18.28 million CVD deaths). Declines in the age-standardized CVD death rate occurred between 1990 and 2015 in all high-income and some middle-income countries. Ischemic heart disease was the leading cause of CVD health lost globally, as well as in each world region, followed by stroke. As SDI increased beyond 0.25, the highest CVD mortality shifted from women to men. CVD mortality decreased sharply for both sexes in countries with an SDI >0.75. CONCLUSIONS: CVDs remain a major cause of health loss for all regions of the world. Sociodemographic change over the past 25 years has been associated with dramatic declines in CVD in regions with very high SDI, but only a gradual decrease or no change in most regions. Future updates of the GBD study can be used to guide policymakers who are focused on reducing the overall burden of noncommunicable disease and achieving specific global health targets for CVD. ER -